MedTrace Logo

Effect of Metformin and Probiotics in Reproductive-aged Patients With Polycystic Ovary Syndrome

NCT03336840 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2019-02-01

No results posted yet for this study

Summary

The purpose of this clinical trial is to evaluate the safety and effectiveness on the clinical and biological parameters of reproductive-aged PCOS women after a 12-week metformin and/or probiotics administration.

Conditions

  • Polycystic Ovary Syndrome

Interventions

DRUG

Metformin tablets

0.5g (1 pill) of Metformin tablets administered three times a day orally before meal

DRUG

ProMetS probiotics powder

4g (2 strips) of ProMetS probiotics powder administered orally every night

DRUG

1. Metformin tablets; 2. ProMetS probiotics powder

1. 0.5g (1 pill) of Metformin tablets administered three times a day orally before meal; 2. 4g (2 strips) of ProMetS probiotics powder administered orally every night

Sponsors & Collaborators

  • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2019-03-31
Completion
2019-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03336840 on ClinicalTrials.gov